PAVmed Stock Price, News & Analysis (NASDAQ:PAVM)

$1.85 -0.69 (-27.17 %)
(As of 01/21/2018 04:00 PM ET)
Previous Close$1.85
Today's Range$1.76 - $1.87
52-Week Range$1.76 - $9.31
Volume635,972 shs
Average Volume50,919 shs
Market Capitalization$31.01 million
P/E Ratio-1.99
Dividend YieldN/A
BetaN/A

About PAVmed (NASDAQ:PAVM)

PAVmed Inc. operates as a medical device company in the United States. Its product pipeline includes PortIO, a long-term implantable vascular access device; CarpX, a percutaneous device to treat carpal tunnel syndrome; NextCath, a self-anchoring catheter; DisappEAR: Antibiotic-eluting resorbable ear tube; NextFlo, a disposable infusion pump; and Caldus, a disposable tissue ablation device. The company was formerly known as PAXmed Inc. and changed its name to PAVmed Inc. in April 2015. PAVmed Inc. was founded in 2014 and is based in New York, New York.

Receive PAVM News and Ratings via Email

Sign-up to receive the latest news and ratings for PAVM and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry N/A
Sub-IndustryN/A
SectorMedical
SymbolNASDAQ:PAVM
CUSIPN/A
Phone212-949-4319

Debt

Debt-to-Equity Ratio-0.26%
Current Ratio0.42%
Quick Ratio0.42%

Price-To-Earnings

Trailing P/E Ratio-1.98924731182796
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book Value($0.02) per share
Price / Book-92.50

Profitability

Trailing EPS($0.93)
Net Income$-5,650,000.00
Net MarginsN/A
Return on EquityN/A
Return on Assets-700.04%

Miscellaneous

Employees3
Outstanding Shares14,550,000

PAVmed (NASDAQ:PAVM) Frequently Asked Questions

What is PAVmed's stock symbol?

PAVmed trades on the NASDAQ under the ticker symbol "PAVM."

How were PAVmed's earnings last quarter?

PAVmed Inc. (NASDAQ:PAVM) announced its quarterly earnings data on Wednesday, November, 15th. The company reported ($0.14) earnings per share (EPS) for the quarter, meeting the Zacks' consensus estimate of ($0.14). View PAVmed's Earnings History.

When will PAVmed make its next earnings announcement?

PAVmed is scheduled to release their next quarterly earnings announcement on Thursday, February, 15th 2018. View Earnings Estimates for PAVmed.

Where is PAVmed's stock going? Where will PAVmed's stock price be in 2018?

1 brokerages have issued 12-month price objectives for PAVmed's shares. Their forecasts range from $10.10 to $10.10. On average, they anticipate PAVmed's stock price to reach $10.10 in the next year. View Analyst Ratings for PAVmed.

Who are some of PAVmed's key competitors?

How do I buy PAVmed stock?

Shares of PAVmed can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is PAVmed's stock price today?

One share of PAVmed stock can currently be purchased for approximately $1.85.

How big of a company is PAVmed?

PAVmed has a market capitalization of $31.01 million. The company earns $-5,650,000.00 in net income (profit) each year or ($0.93) on an earnings per share basis. PAVmed employs 3 workers across the globe.

How can I contact PAVmed?

PAVmed's mailing address is ONE GRAND CENTRAL PLACE SUITE 4600, NEW YORK NY, 10165. The company can be reached via phone at 212-949-4319 or via email at [email protected]


MarketBeat Community Rating for PAVmed (PAVM)

Community Ranking:  2.2 out of 5 (star star)
Outperform Votes:  39 (Vote Outperform)
Underperform Votes:  51 (Vote Underperform)
Total Votes:  90
MarketBeat's community ratings are surveys of what our community members think about PAVmed and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

PAVmed (NASDAQ:PAVM) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyN/A
Consensus Rating Score: 3.003.003.00N/A
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $10.10$10.10$10.10N/A
Price Target Upside: 125.60% upside125.60% upside125.60% upsideN/A

PAVmed (NASDAQ:PAVM) Consensus Price Target History

Price Target History for PAVmed (NASDAQ:PAVM)

PAVmed (NASDAQ:PAVM) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
9/5/2017Dawson JamesReiterated RatingBuy$10.10HighView Rating Details
(Data available from 1/21/2016 forward)

Earnings

PAVmed (NASDAQ:PAVM) Earnings History and Estimates Chart

Earnings by Quarter for PAVmed (NASDAQ:PAVM)

PAVmed (NASDAQ PAVM) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
2/15/2018        
11/15/2017Q3 2017($0.14)($0.14)ViewN/AView Earnings Details
8/14/2017Q2 2017($0.14)($0.13)ViewN/AView Earnings Details
5/22/2017Q1 2017($0.32)ViewN/AView Earnings Details
2/16/2017Q4 2016($0.13)ViewN/AView Earnings Details
11/10/2016Q3 2016($0.14)ViewN/AView Earnings Details
8/16/2016Q2 2016($0.09)($0.10)ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Estimates

PAVmed (NASDAQ:PAVM) Earnings Estimates

No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for PAVmed (NASDAQ:PAVM)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

PAVmed (NASDAQ PAVM) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 79.30%
Institutional Ownership Percentage: 0.74%
Insider Trades by Quarter for PAVmed (NASDAQ:PAVM)

PAVmed (NASDAQ PAVM) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
9/13/2017Lishan AklogChairmanBuy700$0.95$665.0065,738View SEC Filing  
9/7/2017Lishan AklogChairman and CEOBuy1,250$5.39$6,737.5065,438View SEC Filing  
8/24/2017Dennis M McgrathCFOBuy3,000$4.22$12,660.00View SEC Filing  
8/23/2017Dennis M McgrathCFOBuy3,000$4.11$12,330.00View SEC Filing  
8/22/2017Dennis M McgrathCFOBuy6,000$4.21$25,260.00View SEC Filing  
8/16/2017Lishan AklogChairmanBuy1,885$3.27$6,163.9528,877View SEC Filing  
11/29/2016Lishan AklogChairmanBuy2,777$9.21$25,576.1726,600View SEC Filing  
11/23/2016Lishan AklogChairmanBuy2,200$8.98$19,756.0025,600View SEC Filing  
11/21/2016Lishan AklogChairmanBuy2,300$10.02$23,046.0022,500View SEC Filing  
11/18/2016Joshua R LamsteinDirectorBuy200$10.95$2,190.0083,617View SEC Filing  
9/16/2016Lishan AklogChairmanBuy1,300$14.05$18,265.0020,100View SEC Filing  
9/14/2016Lishan AklogChairmanBuy1,500$13.40$20,100.0018,400View SEC Filing  
8/26/2016Lishan AklogChairmanBuy400$14.30$5,720.0018,300View SEC Filing  
8/24/2016Lishan AklogChairmanBuy1,500$14.22$21,330.0016,600View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

PAVmed (NASDAQ PAVM) News Headlines

Source:
DateHeadline
PAVmed (PAVM) Prices 2.42M Share Common Offering at $1.80/ShPAVmed (PAVM) Prices 2.42M Share Common Offering at $1.80/Sh
www.streetinsider.com - January 19 at 9:45 AM
BRIEF-Pavmed Announces Pricing Of Firm Commitment Common Stock OfferingBRIEF-Pavmed Announces Pricing Of Firm Commitment Common Stock Offering
www.reuters.com - January 19 at 9:45 AM
PAVmed Announces Firm Commitment Public Offering of Common StockPAVmed Announces Firm Commitment Public Offering of Common Stock
finance.yahoo.com - January 19 at 9:45 AM
BRIEF-PAVmed Sets Terms Of Previously Announced Rights OfferingBRIEF-PAVmed Sets Terms Of Previously Announced Rights Offering
www.reuters.com - January 17 at 8:31 AM
PAVmed Sets Terms of Previously Announced Rights OfferingPAVmed Sets Terms of Previously Announced Rights Offering
finance.yahoo.com - January 17 at 8:31 AM
PAVmed Initiates Reduction in Exercise Price of Series W WarrantsPAVmed Initiates Reduction in Exercise Price of Series W Warrants
finance.yahoo.com - January 11 at 9:06 AM
PAVmed Announces Temporary Offer Allowing Warrants to Be Exercised at a Reduced PricePAVmed Announces Temporary Offer Allowing Warrants to Be Exercised at a Reduced Price
finance.yahoo.com - January 9 at 6:09 PM
Form 4 PAVmed Inc. For: Dec 21 Filed by: Lamstein Joshua RForm 4 PAVmed Inc. For: Dec 21 Filed by: Lamstein Joshua R
www.streetinsider.com - December 28 at 5:18 PM
Fierce Innovation Awards 2017 Recognizes PAVmed’s CarpX™ Device for Technology InnovationFierce Innovation Awards 2017 Recognizes PAVmed’s CarpX™ Device for Technology Innovation
finance.yahoo.com - December 18 at 8:56 AM
Wired News – CHF Solutions Partners with TRANSMEDIC for Marketing and Distribution of Aquadex FlexFlow(R) System in SingaporeWired News – CHF Solutions Partners with TRANSMEDIC for Marketing and Distribution of Aquadex FlexFlow(R) System in Singapore
finance.yahoo.com - December 15 at 9:07 AM
BRIEF-Pavmed Files 510(K) Submission With Fda For Carpx Device To Treat Carpal Tunnel SyndromeBRIEF-Pavmed Files 510(K) Submission With Fda For Carpx Device To Treat Carpal Tunnel Syndrome
www.reuters.com - November 28 at 5:54 PM
PAVmed Files 510(k) Submission with FDA for CarpX™ Device to Treat Carpal Tunnel SyndromePAVmed Files 510(k) Submission with FDA for CarpX™ Device to Treat Carpal Tunnel Syndrome
finance.yahoo.com - November 28 at 10:32 AM
PAVmed Inc. (PAVM) Set to Announce Quarterly Earnings on ThursdayPAVmed Inc. (PAVM) Set to Announce Quarterly Earnings on Thursday
www.americanbankingnews.com - November 23 at 1:30 AM
What You Must Know About PAVmed Inc’s (PAVM) Major InvestorsWhat You Must Know About PAVmed Inc’s (PAVM) Major Investors
finance.yahoo.com - November 22 at 6:34 AM
PAVmed Reports Third Quarter 2017 Financial ResultsPAVmed Reports Third Quarter 2017 Financial Results
finance.yahoo.com - November 18 at 10:48 AM
PAVmed to Host Earnings CallPAVmed to Host Earnings Call
finance.yahoo.com - November 18 at 10:48 AM
PAVmed Inc. (PAVM) to Release Earnings on ThursdayPAVmed Inc. (PAVM) to Release Earnings on Thursday
www.americanbankingnews.com - November 11 at 8:48 AM
PAVmed Inc. to Hold Business Update Conference Call on November 16thPAVmed Inc. to Hold Business Update Conference Call on November 16th
finance.yahoo.com - November 9 at 11:03 AM
PAVmed (PAVM) Presents At 3rd Annual Dawson James Small Cap Growth Conference 2017 - lideshowPAVmed (PAVM) Presents At 3rd Annual Dawson James Small Cap Growth Conference 2017 - lideshow
seekingalpha.com - October 22 at 8:01 PM
PAVmed to Present at Dawson James Securities 3rd Annual Small Cap Growth ConferencePAVmed to Present at Dawson James Securities 3rd Annual Small Cap Growth Conference
finance.yahoo.com - October 11 at 6:26 AM
BRIEF-Pavmed says has received a letter from FDA regarding its portio intraosseous infusion systemBRIEF-Pavmed says has received a letter from FDA regarding its portio intraosseous infusion system
www.businessinsider.com - October 5 at 3:04 PM
PAVmed to Present at the Cantor Fitzgerald Global Healthcare ConferencePAVmed to Present at the Cantor Fitzgerald Global Healthcare Conference
finance.yahoo.com - September 19 at 6:22 AM
PAVmed Inc. to Hold Business Update Conference Call on August 17thPAVmed Inc. to Hold Business Update Conference Call on August 17th
finance.yahoo.com - September 14 at 4:41 PM
PAVmed Reports Second Quarter 2017 Financial ResultsPAVmed Reports Second Quarter 2017 Financial Results
finance.yahoo.com - September 14 at 4:41 PM
PAVmeds (PAVM) Buy Rating Reiterated at Dawson JamesPAVmed's (PAVM) Buy Rating Reiterated at Dawson James
www.americanbankingnews.com - September 5 at 3:34 PM
Dennis M. Mcgrath Acquires 3,000 Shares of PAVmed Inc. (PAVM) StockDennis M. Mcgrath Acquires 3,000 Shares of PAVmed Inc. (PAVM) Stock
www.americanbankingnews.com - August 28 at 10:24 AM
Insider Buying: PAVmed Inc. (PAVM) CFO Purchases 3,000 Shares of StockInsider Buying: PAVmed Inc. (PAVM) CFO Purchases 3,000 Shares of Stock
www.americanbankingnews.com - August 24 at 10:32 AM
PAVmed Inc. (PAVM) CFO Dennis M. Mcgrath Buys 6,000 SharesPAVmed Inc. (PAVM) CFO Dennis M. Mcgrath Buys 6,000 Shares
www.americanbankingnews.com - August 23 at 10:34 AM
PAVmed Inc. (PAVM) Issues  Earnings ResultsPAVmed Inc. (PAVM) Issues Earnings Results
www.americanbankingnews.com - August 15 at 1:10 PM
PAVmed Inc. (PAVM) to Release Quarterly Earnings on MondayPAVmed Inc. (PAVM) to Release Quarterly Earnings on Monday
www.americanbankingnews.com - August 11 at 8:54 PM

SEC Filings

PAVmed (NASDAQ:PAVM) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

PAVmed (NASDAQ:PAVM) Income Statement, Balance Sheet and Cash Flow Statement

Chart

PAVmed (NASDAQ PAVM) Stock Chart for Sunday, January, 21, 2018

Loading chart…

This page was last updated on 1/21/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.